Sippican Capital Advisors Johnson & Johnson Transaction History

Sippican Capital Advisors

$130 Million
Q3 2024

A detailed history of Sippican Capital Advisors transactions in Johnson & Johnson stock. As of the latest transaction made, Sippican Capital Advisors holds 4,076 shares of JNJ stock, worth $631,820. This represents 0.51% of its overall portfolio holdings.

Number of Shares

4,076

Previous 6,476 37.06%

Holding current value

$631,820

Previous $946,000 30.23%

% of portfolio

0.51%

Previous 0.81%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$145.48 - $167.38 $349,152 - $401,712	-2,400 Reduced 37.06%	4,076 $660,000
Q2 2024 Aug 06, 2024	BUY	$144.38 - $157.78 $3,609 - $3,944	25 Added 0.39%	6,476 $946,000
Q1 2024 May 02, 2024	SELL	$155.22 - $162.74 $54,327 - $56,959	-350 Reduced 5.15%	6,451 $1.02 Million
Q4 2023 Jan 30, 2024	BUY	$145.6 - $158.88 $47,320 - $51,636	325 Added 5.02%	6,801 $1.07 Million
Q3 2023 Oct 24, 2023	BUY	$155.75 - $174.48 $140,642 - $157,555	903 Added 16.2%	6,476 $1.01 Million
Q3 2022 Oct 17, 2022	SELL	$161.33 - $179.52 $4,033 - $4,488	-25 Reduced 0.45%	5,573 $910,000
Q2 2022 Jul 19, 2022	SELL	$168.19 - $186.01 $4,204 - $4,650	-25 Reduced 0.44%	5,598 $994,000
Q1 2022 Apr 20, 2022	SELL	$158.14 - $179.59 $474 - $538	-3 Reduced 0.05%	5,623 $997,000
Q3 2021 Oct 20, 2021	BUY	$161.5 - $179.47 $8,075 - $8,973	50 Added 0.9%	5,626 $909,000
Q2 2021 Jul 22, 2021	BUY	$159.48 - $171.07 $14,193 - $15,225	89 Added 1.62%	5,576 $919,000
Q1 2021 Apr 15, 2021	BUY	$153.07 - $170.48 $24,950 - $27,788	163 Added 3.06%	5,487 $902,000
Q4 2020 Jan 21, 2021	SELL	$137.11 - $157.38 $6,855 - $7,869	-50 Reduced 0.93%	5,324 $838,000
Q3 2020 Oct 23, 2020	SELL	$140.38 - $153.83 $1,544 - $1,692	-11 Reduced 0.2%	5,374 $800,000
Q2 2020 Jul 15, 2020	SELL	$128.81 - $155.51 $43,795 - $52,873	-340 Reduced 5.94%	5,385 $757,000
Q1 2020 Apr 16, 2020	SELL	$111.14 - $153.99 $27,673 - $38,343	-249 Reduced 4.17%	5,725 $751,000
Q4 2019 Jan 21, 2020	BUY	$127.5 - $146.44 $38,887 - $44,664	305 Added 5.38%	5,974 $871,000
Q3 2019 Oct 17, 2019	SELL	$126.95 - $142.14 $19,296 - $21,605	-152 Reduced 2.61%	5,669 $733,000
Q2 2019 Jul 17, 2019	SELL	$131.15 - $144.24 $20,984 - $23,078	-160 Reduced 2.68%	5,821 $811,000
Q1 2019 Apr 17, 2019	SELL	$125.72 - $139.79 $32,687 - $36,345	-260 Reduced 4.17%	5,981 $836,000
Q4 2018 Jan 16, 2019	SELL	$122.84 - $147.84 $7,370 - $8,870	-60 Reduced 0.95%	6,241 $805,000
Q3 2018 Nov 13, 2018	SELL	$121.58 - $142.88 $3,039 - $3,572	-25 Reduced 0.4%	6,301 $916,000
Q2 2018 Jul 17, 2018	BUY	$119.4 - $131.76 $159,637 - $176,163	1,337 Added 26.8%	6,326 $768,000
Q1 2018 Apr 24, 2018	BUY	$125.1 - $148.14 $96,327 - $114,067	770 Added 18.25%	4,989 $639,000
Q4 2017 Jan 17, 2018	SELL	$131.22 - $143.62 $14,434 - $15,798	-110 Reduced 2.54%	4,219 $589,000
Q3 2017 Oct 30, 2017	BUY	$129.47 - $135.38 $560,475 - $586,060	4,329	4,329 $563,000

Others Institutions Holding JNJ

# of Institutions

4,272

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $405B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sippican Capital Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Sippican Capital Advisors with notifications on news.

Account

Sippican Capital Advisors Johnson & Johnson Transaction History